Tag: The Multidisciplinary Association for Psychedelic Studies

MDMA will be approved to aid therapy for PTSD suffers by 2021: research group
MDMA will be approved to aid therapy for PTSD suffers by 2021: research group

For the first time in decades, Canadian researchers are probing the potential of a psychedelic drug – ecstasy – for use in psychotherapy in a clinical trial approved by Health Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS), is investigating the use of MDMA, the pure form of the party drug ecstasy, to assist therapy sessions for people with treatment-resistant…

Learn more